The Siemens Industry Automation Division has therefore equipped the devices with the relevant interfaces. The CPU 319-3 PN/DP for the Simatic S7-300, the Profinet CPUs of the Simatic S7-400, a new Profinet CPU for the ET 200S distributed I/O system and the new Simatic S7-mEC embedded controller have IRT capability.
IRT is especially suitable for large machines and equipment with short updating times and a large number of nodes in a linear arrangement. IRT is also advantageous when automation data and a high volume of standard Ethernet data, for example via TCP/IP, have to be transferred within a network.
IRT Profinet divides the medium bandwidth into two intervals. One of them is reserved for the fast and deterministic transfer of automation data while the other is used for standard Ethernet data which are not time-critical. The FSU (Fast Start Up) function enables Profinet IO devices connected to the network to power up within one second.
This is extremely useful in robot applications, for example, where rapid re-tooling is necessary. The integrated web server provides user-friendly diagnostic functions, for example for the topology of the entire network or the status of the connected Profinet and Profibus field devices. Important web information, such as variable status and tables as well as the status of field devices, is updated automatically.
Gerhard Stauss | Siemens Industry Automation
Fine-tuning for additive production
15.11.2019 | Fraunhofer-Institut für Werkstoff- und Strahltechnik IWS
Efficient engine production with the latest generation of the LZH IBK
13.11.2019 | Laser Zentrum Hannover e.V.
Graphene, a two-dimensional structure made of carbon, is a material with excellent mechanical, electronic and optical properties. However, it did not seem suitable for magnetic applications. Together with international partners, Empa researchers have now succeeded in synthesizing a unique nanographene predicted in the 1970s, which conclusively demonstrates that carbon in very specific forms has magnetic properties that could permit future spintronic applications. The results have just been published in the renowned journal Nature Nanotechnology.
Depending on the shape and orientation of their edges, graphene nanostructures (also known as nanographenes) can have very different properties – for example,...
Using a clever technique that causes unruly crystals of iron selenide to snap into alignment, Rice University physicists have drawn a detailed map that reveals...
University of Texas and MIT researchers create virtual UAVs that can predict vehicle health, enable autonomous decision-making
In the not too distant future, we can expect to see our skies filled with unmanned aerial vehicles (UAVs) delivering packages, maybe even people, from location...
With ultracold chemistry, researchers get a first look at exactly what happens during a chemical reaction
The coldest chemical reaction in the known universe took place in what appears to be a chaotic mess of lasers. The appearance deceives: Deep within that...
Abnormal scarring is a serious threat resulting in non-healing chronic wounds or fibrosis. Scars form when fibroblasts, a type of cell of connective tissue, reach wounded skin and deposit plugs of extracellular matrix. Until today, the question about the exact anatomical origin of these fibroblasts has not been answered. In order to find potential ways of influencing the scarring process, the team of Dr. Yuval Rinkevich, Group Leader for Regenerative Biology at the Institute of Lung Biology and Disease at Helmholtz Zentrum München, aimed to finally find an answer. As it was already known that all scars derive from a fibroblast lineage expressing the Engrailed-1 gene - a lineage not only present in skin, but also in fascia - the researchers intentionally tried to understand whether or not fascia might be the origin of fibroblasts.
Fibroblasts kit - ready to heal wounds
03.12.2019 | Event News
15.11.2019 | Event News
15.11.2019 | Event News
10.12.2019 | Architecture and Construction
10.12.2019 | Information Technology
10.12.2019 | Life Sciences